Comparative analysis of valproic acid concentrations in terms of dosing and clinical effect monitoring in different age patients with diagnosed epilepsy
Subject of research Therapy drug monitoring under the control of valproic acid (VPA) is now a well-established tool for the treatment of epilepsy. The pharmacokinetic variability of VPA and inter-individual differences in epilepsy type/seizure severity depending on patients’ age determine serum conc...
Main Authors: | Agnieszka Cios, Elżbieta Szczygieł-Pilut, Sylwia Kozłowska, Anna Zajączkowska-Dutkiewicz, Łukasz Hońdo, Anna Wesołowska |
---|---|
Format: | Article |
Language: | Polish |
Published: |
Polish Pharmaceutical Society
2022-05-01
|
Series: | Farmacja Polska |
Subjects: | |
Online Access: | https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2022%2F3%2F01_OG_Kwas_walproinowy_n.pdf |
Similar Items
-
Therapeutic monitoring of valproic acid - benefits and problems
by: Agnieszka Małgorzata Cios, et al.
Published: (2021-05-01) -
Serum concentrations of valproic acid in people with epilepsy: Clinical implication
by: Angel T. Alvarado, et al.
Published: (2022-11-01) -
Valproic acid-associated pancytopenia: A dose-dependent adverse effect
by: Jamir Pitton Rissardo, et al.
Published: (2019-09-01) -
Cost analysis of epilepsy pharmacotherapy by valproic acid and carbamazepine
by: Ia. O. Grynkiv, et al.
Published: (2018-08-01) -
Meta-analysis of plasma homocysteine levels in valproic acid treated patients with epilepsy
by: Guan-zhong NI, et al.
Published: (2014-12-01)